OR WAIT null SECS
December 07, 2022
One can improve method precision and productivity by replacing one step in sample preparation with an automated approach.
Advancing digital transformation can significantly reduce R&D costs and shorten drug discovery timelines.
November 21, 2022
Biotech startup, Cradle, has raised $5.4 million in seed funding with an AI-enabled design platform that allows for the synthetic building of cell factories to produce proteins.
Element has opened a new 7500-ft3 facility that will be used to evaluate aerosolized product efficacy for reducing airborne organisms and viral particles.
November 02, 2022
Replacing a step in sample preparation with an automated approach improves both method precision and productivity.
Single-use systems can benefit from standardized risk assessment and analysis protocols, which can facilitate the way in which processing equipment components are compared.
With the evolution of scalability of peripheral blood protein glycosylation, research has expanded for new biomarkers.
October 10, 2022
OGT has launched the SureSeq Myeloid Plus panel and OGT Universal NGS Complete Workflow.
October 05, 2022
Production of viral vectors requires a holistic view of the product, including its manufacturing process and its ultimate end use.
September 09, 2022
Avance Clinical’s acquisition of C3 Research Associates expands its CRO services to North America.